Published:
Last updated:
zie Nederlandse samenvatting
ID
NL-OMON40585
Source
ToetsingOnline
Brief title
Early Raynaud Clinic
Condition
- Autoimmune disorders
- Connective tissue disorders (excl congenital)
- Skin vascular abnormalities
Synonym
Scleroderma, Systemic Sclerosis
Research involving
Human
Sponsors and support
Primary sponsor
:
Leids Universitair Medisch Centrum
Source(s) of monetary or material Support
:
afdeling reumatologie
Intervention
Keyword
:
Capillaroscopy, Diagnostic value, Raynaud
Outcome measures
Primary outcome
zie Nederlandse samenvatting
Secondary outcome
zie Nederlandse samenvatting
Background summary
zie Nederlandse samenvatting
Study objective
zie Nederlandse samenvatting
Study design
zie Nederlandse samenvatting
Study burden and risks
zie Nederlandse samenvatting
Public
Leids Universitair Medisch Centrum
Albinusdreef 2
Leiden 2333 ZA
NL
Albinusdreef 2
Leiden 2333 ZA
NL
Scientific
Leids Universitair Medisch Centrum
Albinusdreef 2
Leiden 2333 ZA
NL
Albinusdreef 2
Leiden 2333 ZA
NL
Listed location countries
Netherlands
Age
Adults (18-64 years)
Elderly (65 years and older)
Inclusion criteria
Raynaud's phenomenon
age 18 years or older
informed consent given
Exclusion criteria
no
Design
Study type
:
Observational non invasive
Masking
:
Open (masking not used)
Control
:
Uncontrolled
Primary purpose
:
Diagnostic
Recruitment
NL
Recruitment status
:
Recruiting
Start date (anticipated)
:
Enrollment
:
154
Type
:
Actual
Approved WMO
Date
:
Application type
:
First submission
Review commission
:
METC Leiden-Den Haag-Delft (Leiden)
metc-ldd@lumc.nl
Approved WMO
Date
:
Application type
:
Amendment
Review commission
:
METC Leiden-Den Haag-Delft (Leiden)
metc-ldd@lumc.nl
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL46284.058.13 |